Literature DB >> 16456528

Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions.

Christine Casey1, Claudia Vellozzi, Gina T Mootrey, Louisa E Chapman, Mary McCauley, Martha H Roper, Inger Damon, David L Swerdlow.   

Abstract

CDC and the U.S. Food and Drug Administration rely on state and local health departments, health-care providers, and the public to report the occurrence of adverse events after vaccination to the Vaccine Adverse Event Reporting System. With such data, trends can be accurately monitored, unusual occurrences of adverse events can be detected, and the safety of vaccination intervention activities can be evaluated. On January 24, 2003, the U.S. Department of Health and Human Services (DHHS) implemented a preparedness program in which smallpox (vaccinia) vaccine was administered to federal, state, and local volunteers who might be first responders during a biologic terrorism event. As part of the DHHS Smallpox Preparedness and Response Program, CDC in consultation with experts, established surveillance case definitions for adverse events after smallpox vaccination. Adverse reactions after smallpox vaccination identified during the 1960s surveillance activities were classified on the basis of clinical description and included eczema vaccinatum; fetal vaccinia; generalized vaccinia; accidental autoinoculation, nonocular; ocular vaccinia; progressive vaccinia; erythema multiforme major; postvaccinial encephalitis or encephalomyelitis; and pyogenic infection of the vaccination site. This report provides uniform criteria used for the surveillance case definition and classification for these previously recognized adverse reactions used during the DHHS Smallpox Preparedness and Response Program. Inadvertent inoculation was changed to more precisely describe this event as inadvertent autoinoculation and contact transmission, nonocular and ocular vaccinia. Pyogenic infection also was renamed superinfection of the vaccination site or regional lymph nodes. Finally, case definitions were developed for a new cardiac adverse reaction (myo/pericarditis) and for a cardiac adverse event (dilated cardiomyopathy) and are included in this report. The smallpox vaccine surveillance case definitions presented in the report can be used in future vaccination programs to ensure uniform reporting guidelines and case classification.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16456528

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  12 in total

1.  Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System.

Authors:  Michael M McNeil; Maria Cano; Elaine R Miller; Brett W Petersen; Renata J M Engler; Marthe G Bryant-Genevier
Journal:  Vaccine       Date:  2014-06-18       Impact factor: 3.641

Review 2.  Deaths following vaccination: What does the evidence show?

Authors:  Elaine R Miller; Pedro L Moro; Maria Cano; Tom T Shimabukuro
Journal:  Vaccine       Date:  2015-05-23       Impact factor: 3.641

Review 3.  Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.

Authors:  Stephen R Walsh; Raphael Dolin
Journal:  Expert Rev Vaccines       Date:  2011-08       Impact factor: 5.217

4.  Can vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants?

Authors:  Holger F Rabenau; Ingrid Rapp; Jochen Steinmann
Journal:  BMC Infect Dis       Date:  2010-06-23       Impact factor: 3.090

5.  Electrocardiography screening for cardiotoxicity after modified Vaccinia Ankara vaccination.

Authors:  Junko Sano; Bernard R Chaitman; Jason Swindle; Sharon E Frey
Journal:  Am J Med       Date:  2009-01       Impact factor: 4.965

6.  Encephalitis after secondary smallpox vaccination.

Authors:  Vlada V Melekhin; Kevin L Karem; Inger K Damon; Karen C Bloch
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

7.  Finding and removing highly connected individuals using suboptimal vaccines.

Authors:  Beatriz Vidondo; Markus Schwehm; Andrea Bühlmann; Martin Eichner
Journal:  BMC Infect Dis       Date:  2012-03-03       Impact factor: 3.090

8.  Secondary and tertiary transmission of vaccinia virus from US military service member.

Authors:  Gregory E Young; Christina M Hidalgo; Ann Sullivan-Frohm; Cynthia Schult; Stephen Davis; Cassandra Kelly-Cirino; Christina Egan; Kimberly Wilkins; Ginny L Emerson; Kimberly Noyes; Debra Blog
Journal:  Emerg Infect Dis       Date:  2011-04       Impact factor: 6.883

9.  Vaccinia virus infections in martial arts gym, Maryland, USA, 2008.

Authors:  Christine M Hughes; David Blythe; Yu Li; Ramani Reddy; Carol Jordan; Cindy Edwards; Celia Adams; Holly Conners; Catherine Rasa; Sue Wilby; Jamaal Russell; Kelly S Russo; Patricia Somsel; Danny L Wiedbrauk; Cindy Dougherty; Christopher Allen; Mike Frace; Ginny Emerson; Victoria A Olson; Scott K Smith; Zachary Braden; Jason Abel; Whitni Davidson; Mary Reynolds; Inger K Damon
Journal:  Emerg Infect Dis       Date:  2011-04       Impact factor: 6.883

10.  Demographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteers.

Authors:  Philippe Bossi; Frédérick Gay; Imène Fouzai; Béhazine Combadière; Geneviève Brousse; Bénédicte Lebrun-Vignes; Jean-Marc Crance; Brigitte Autran; Daniel Garin
Journal:  PLoS One       Date:  2008-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.